PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and m...
| Model | Near-Term (0-3 mo.) | Mid-Term (3-12 mo.) | Long-Term (1-5 yr.) |
|---|---|---|---|
| Deepseek | Buy | Hold | Buy |
| OpenAI | Buy | Buy | Hold |
| Gemini | Buy | Hold | Hold |
| Grok | Buy | Hold | Buy |
Current price is above the fifty-day average, indicating short-term bullish momentum.
Expected stability with potential for gradual growth as valuation catches up.
Strong fundamentals and sector growth prospects support long-term appreciation.
Price above 50-day average and low beta suggest short-term upside potential.
Fair valuation and sector stability suggest holding for moderate returns.
Stable healthcare sector and low beta indicate long-term stability.
PFE shows a strong recovery trend and attractive valuation metrics.
Continued growth expected with stable market and sector performance.
Long-term outlook is stable, but dependent on future innovations and market conditions.
Current price above 50-day average signals short-term strength. Potential for upward momentum exists.
Price near 200-day average suggests limited upside. Stability expected without significant catalysts.
Low beta and undervaluation support long-term growth. Healthcare sector remains resilient.
